RISK OF SKIN CANCER FOLLOWING ANTI-TUMOUR NECROSIS FACTOR TREATMENT IN RHEUMATOID AND PSORIATIC ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW

被引：0
|
作者：
Chatterjea, R. [1 ]
Mc Laughlin, M. [2 ]
Kuhn, I. L. [3 ]
Ostor, A. [2 ]
机构：
[1] Univ Cambridge, Cambridge, England
[2] Addenbrookes Hosp, Rheumatol Res Unit, Cambridge, England
[3] Univ Cambridge, Univ Lib, Med Lib, Cambridge, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.6524
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0170
引用
收藏
页码：715 / 715
页数：1
相关论文
共 50 条
  • [1] RISK OF SKIN CANCER FOLLOWING ANTI-TUMOUR NECROSIS FACTOR TREATMENT IN RHEUMATOID AND PSORIATIC ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW
    Chatterjea, Rhea
    Mc Laughlin, Maeve
    Kuhn, Isla L.
    Oestoer, Andrew
    [J]. RHEUMATOLOGY, 2015, 54 : 72 - 73
  • [2] ANTI-TUMOUR NECROSIS FACTOR (TNF) DRUGS FOR THE TREATMENT OF PSORIATIC ARTHRITIS (PSA)
    Farrell, J.
    Mills, E.
    Sheppard, O.
    Thorlund, K.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A440 - A440
  • [3] Retention of tocilizumab and anti-tumour necrosis factor drugs in the treatment of rheumatoid arthritis
    Hishitani, Y.
    Ogata, A.
    Shima, Y.
    Hirano, T.
    Ebina, K.
    Kunugiza, Y.
    Shi, K.
    Narazaki, M.
    Hagihara, K.
    Tomita, T.
    Yoshikawa, H.
    Tanaka, T.
    Kumanogoh, A.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2013, 42 (04) : 253 - 259
  • [4] Neutropenia while receiving anti-tumour necrosis factor treatment for rheumatoid arthritis
    Rajakulendran, S.
    Gadsby, K.
    Allen, D.
    O'Reilly, S.
    Deighton, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (12) : 1678 - 1679
  • [5] Peptostreptococcal pericarditis complicating anti-tumour necrosis factor α treatment in rheumatoid arthritis
    Harney, S
    O'Shea, FD
    FitzGerald, O
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (07) : 653 - 654
  • [6] Anti-tumour necrosis factor treatment in HIV-positive patients with psoriatic arthritis
    Cobo Ibanez, Tatiana
    Zamora, Francisco
    Herranz, Pedro
    Steiner, Martina
    [J]. MEDICINA CLINICA, 2009, 133 (17): : 682 - 683
  • [7] The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis
    Askling, Johan
    Dixon, Will
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (02) : 138 - 144
  • [8] ANTI-TUMOUR NECROSIS FACTOR THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS DOES NOT ATTENUATE CUTANEOUS TUMOUR NECROSIS FACTOR ACTIVITY FOLLOWING A TUBERCULIN SKIN TEST
    Byng-Maddick, Rachel
    Haas, Carolin
    Ehrenstein, Michael
    Noursadeghi, Mahdad
    [J]. RHEUMATOLOGY, 2016, 55 : 146 - 146
  • [9] Exacerbation of psoriatic skin lesions in patients with psoriatic arthritis receiving anti-tumour necrosis factor-alpha therapy: description of 3 cases and review of the literature
    Mourao, A. F.
    Rustin, M.
    Isenberg, D.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (03) : 408 - 410
  • [10] Association of previous treatment with anti-tumour necrosis factor inhibitors with the effectiveness of secukinumab in the treatment of psoriatic arthritis: systematic review and meta-analysis
    Xu, Yantao
    Li, Yuting
    Dong, Mengyuan
    Gao, Zi'ang
    Chen, Xiang
    Liu, Hong
    Shen, Minxue
    [J]. RHEUMATOLOGY, 2020, 59 (12) : 3657 - 3665
12345